Details of the Drug

General Information of Drug (ID: DME2P45)

• Drug Name: QGE-031

Indication

Disease Entry	ICD 11	Status	REF
Chronic idiopathic urticaria	EB00.1	Phase 3	[1]
Thyroid cancer	2D10	Phase 2	[2]

• Cross-matching ID: TTD ID: D0J7CH
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT02336425) Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma. U.S. National Institutes of Health.